Evaluation of the Efficacy of Single Anastomosis Sleeve Ileal (SASI) Bypass for Patients with Morbid Obesity: a Multicenter Study.
Summary (3 min read)
Introduction
- Obesity and type 2 diabetes mellitus (T2DM) have become major public health problems [1] and bariatric surgery is now recognized to be the most effective treatment for T2DM in obese patients [2].
- Malabsorptive procedures represent a common strategy in bariatric surgery.
- The SG þ TB is similar to the duodenal switch (DS) but does not completely exclude the duodenum in order to minimize nutritional complications.
- The distal gut hormones such as GLP-1 have central satietogenic effects, and they also reduce gastric emptying which is known as the ileal break mechanism [13].
- The first report on the efficacy of the SASI bypass in patients with morbid obesity demonstrated excellent results of the new procedure [11].
Study Design
- This is a retrospective, multicenter study of patients with morbid obesity with or without T2DM who underwent the SASI bypass in the period of January 2014 to January 2018.
- Central ethical approval for the study was obtained by the principal investigator from the Research Ethics Committee (code=MOHAP/DXB-REC//MAA/No.15/2019).
- Procedures Implemented to Maintain Confidentiality of Participant’s Data.
- Only the research team was eligible to access the data which was kept anonymous.
Subject Selection
- Adult patients (18–60 years) of both sexes with morbid obesity were included.
- Morbid obesity was defined as a body mass index (BMI) of greater than 40 kg/m2 or greater than 35 kg/m2 with at least one associated comorbidity.
- The authors excluded patients with a previous upper abdominal laparotomy or psychological instability.
- Patients who did not fulfill at least 12 months of follow-up were also excluded from the study.
Study Outcome Measures
- The primary outcomes of the study were as follows: &.
- Secondary outcomes were as follows: & Remission of hypertension was considered if the disease was controlled and the patients was normotensive (BP < 120/80) off antihypertensive medication [14].
- & Remission of sleep apnea was defined as AHI/RDI of less than five off CPAP/BI-PAP on repeat objective testing with polysomnography [14].
- & Postoperative complications were defined as “an undesirable and unintended result of the operation affecting the patient that occurs as a direct result of the operation.” & Changes in nutritional status.
Preoperative Assessment and Preparation
- All patients had a preoperative evaluation including careful history taking, clinical examination, and laboratory investigation including blood glucose, lipid profile, and a thyroid and cortisol hormonal evaluation.
- The diagnosis of T2DM was based on fasting blood glucose concentrations > 126 mg/dl or those patients with a positive history of diabetes and taking antidiabetic medications.
- Routine gastroscopy or gastrografin studies were also performed.
- The liver size was reduced by keeping all patients on a low-calorie protein diet for 2 weeks prior to surgery.
- Deep vein thrombosis prophylaxis started 12 h before surgery with low molecular weight heparin subcutaneous injections.
Surgery
- The patient is placed on the operating table in the French position.
- Posterior attachments between the stomach and pancreas are then divided.
- The table is then changed to the horizontal position and the surgeon moves to the left-hand side of the patient to perform the second part of the operation.
- A methylene blue test is the performed to assess for leaks.
- Proton pump inhibitors are administrated for 4 months postoperatively.
Follow-up
- The study patients were seen as outpatients 2 weeks postoperatively then every month for 12 months.
- Patients were also seen in the clinic if they developed symptoms between their follow-up visits.
- The endpoint of the study was at 1 year after SASI bypass.
- Patients who failed to respond at this time point were excluded from the study.
- Study patients were placed on a low-caloric, protein-rich liquid diet for the first month and then other elements were sequentially introduced under strict dietitian supervision.
Assessments
- Remission or partial improvement in T2DM and other comorbidities were recorded.
- Remission of T2DM was assessed by means of clinical and laboratory parameters; the clinical parameters included reduction of the dose or stoppage of insulin or hypoglycemic medications with normally maintained blood glucose levels.
- The laboratory parameters were fasting blood glucose < 100 mg/dl and HBA1c < 6%.
- The fasting blood sugar level, HbA1c, serum albumin, serum hemoglobin, serum iron, and serum vitamin D were measured and compared with their baseline values.
- Early and delayed procedure-related complications were also recorded.
Data Collected
- For each participating center in this study, there was one person (one of the authors) who performed the SASI bypass and carried out the data collection.
- Patient and outcome data were stored in an electronic registry.
- The data were checked for accuracy and were verified before their collection and extraction into Excel sheets.
- Patients with missing or incorrect data were excluded from the study.
- Postoperative data collection included %TWL, %EWL, change in BMI, and early postoperative complications that occurred during the first month such as infections, bleeding, vomiting, leak, and port site problems.
Statistical Analysis
- Data were analyzed using IBM® SPSS® (version 21.0 for Windows).
- Unless stated otherwise, all data were expressed as the mean ± standard deviation (SD) or as percentages.
- Comparisons of categorical/ordinal variables were performed using chi-square analysis for trends.
- Multiple linear regression analysis was performed to determine the significant independent predictors for higher %TWL after SASI bypass.
- All tests were two-tailed, and the results with p < 0.05 were considered statistically significant.
Patients’ Characteristics
- After screening the records of 605 patients who underwent the SASI bypass in the study period, 54 did not meet the inclusion criteria of the study or had missing data, thus were excluded.
- Ultimately, 551 patients from eight participating centers were included in the study.
- Fifty-eight (10.5%) of the patients underwent the SASI bypass as a rescue procedure after a failed sleeve gastrectomy.
Complications and Readmission
- There were fifty-six (10.1%) complications after the SASI bypass.
- Four (0.72%) patients required readmission within 30 days after surgery.
- Bilious vomiting and diarrhea were treated conservatively with fluids and medications.
- One patient who developed a pulmonary embolism was admitted to the ICU and was treated with intravenous fluids, anticoagulant medications, and thrombolytic therapy.
- Overall, according to the Clavien-Dindo classification, there were 47 (84%) grade I complications, three (5.3%) grade II complications, five (8.9%) grade III complications, and one (1.7%) grade IV complication (Table 5).
Outcome of the SASI Bypass as a Rescue Procedure After Sleeve Gastrectomy
- Fifty-eight patients underwent the SASI bypass as a rescue surgery after sleeve gastrectomy.
- All diabetic patients showed complete remission of T2DM, four (16.6%) patients with hypertension had complete remission, while none of the patients with dyslipidemia or OSAS showed remission of their comorbidity.
- Seven patients developed bilious vomiting after the SASI bypass.
Discussion
- As bariatric surgery now comprises a myriad of different procedures, the selection of each bariatric procedure can be a difficult decision.
- While sleeve gastrectomy has become the most common bariatric procedure in many centers owing to its excellent results [15], a number of drawbacks of the procedure have been recognized.
- Awide variation in %EWL after the SASI bypass was also noted in this study.
- The varying level of experience of the participating surgeons with the procedure could be another possible limitation.
- It is possible that with longer follow-up, there could be significant weight regain, relapse of the comorbid conditions, or significant nutritional deficiencies.
Conclusion
- The SASI bypass is an effective bariatric and metabolic surgical procedure that achieves satisfactory weight loss with remarkable improvement in obesity-related complications, namely T2DM and GERD.
- The procedure is also associated with a good safety profile with complication rates of approximately 10%, and most of which were minor complications.
- Randomized trials comparing the SASI bypass with other commonly performed procedures as the sleeve gastrectomy and the RYGB are needed to establish which procedure is superior.
- Authors’ Contributions TarekMahdy designed the study and participated in data collection, drafting, and revision of the manuscript.
- Scott Shikora participated in drafting and critical supervision of the manuscript.
Did you find this useful? Give us your feedback
Citations
24 citations
24 citations
22 citations
19 citations
Cites background or result from "Evaluation of the Efficacy of Singl..."
...The former study reported performing SASI bypass as a rescue procedure to treat severe reflux after SG with no details on the number or outcome in this subgroup [16]....
[...]
...reported a much lower 1-year %EWL (64%) that was explained by wide variation in surgeon expertise and lack of technical standardization [16]....
[...]
...reported a 92% improvement rate in GERD compared with 80% in this study [16]....
[...]
...reported reversal of one patient (2%) due to excessive weight loss in their initial report [9]; however, the reversal rate was not mentioned in the later multi-center study [16]....
[...]
...5–4%), which is more in line with the purely restrictive procedure [15, 16]....
[...]
16 citations
References
1,818 citations
1,542 citations
292 citations
"Evaluation of the Efficacy of Singl..." refers background or methods in this paper
...& Remission of hypertension was considered if the disease was controlled and the patients was normotensive (BP < 120/80) off antihypertensive medication [14]....
[...]
...& Remission of hyperlipidemia was defined as normal lipid profile off medications [14]....
[...]
...& Remission of GERD was defined as absence of symptoms, no medication use, and normal 24-h pH study [14]....
[...]
...& A partial improvement in T2DM was defined as a reduction of at least 25% of the fasting plasma glucose level and of at least 1% in the hemoglobin A1c level with the use of hypoglycemic medications [14]....
[...]
...& Remission of sleep apnea was defined as AHI/RDI of less than five off CPAP/BI-PAP on repeat objective testing with polysomnography [14]....
[...]
212 citations
203 citations
Related Papers (5)
Frequently Asked Questions (17)
Q2. What are the future works in "Evaluation of the efficacy of single anastomosis sleeve ileal (sasi) bypass for patients with morbid obesity: a multicenter study" ?
One advantage of the SASI bypass, compared with the one anastomosis gastric bypass, is the ability to easily access the biliary system to deal with biliary complications in the future. The authors intend to publish the 5-year outcome of the SASI bypass in another future study once the number of patients who completed 5 years of follow-up has been deemed sufficient.
Q3. What are the limitations of the present study?
Limitations of the present study include its retrospective nature, being associated with inherent risk of selection bias, and the lack of a control group.
Q4. What mechanisms are responsible for the remission of T2DM after the SASI bypass?
Possible mechanisms responsible for the remission of T2DM after the SASI bypass include the restriction of the gastric volume which results in reduction in the caloric intake, the rapid delivery of undigested gastric content into the ileum which has been shown to amplify the nutritive stimulation of the distal gut, and the diminishing of the overstimulation of the proximal gut by having a smaller portion of the meal emptying through the duodenum [11].
Q5. What was the effect of the SASI bypass on T2DM?
The significant reduction of fasting blood glucose and HbA1C at 12 months after the SASI bypass demonstrated the therapeutic impact of the procedure on T2DM.
Q6. How much weight loss was observed after the SASI bypass?
At 12 months after the SASI bypass, a significant decrease in BMI was observed (from 43.2 ± 12.5 to 31.2 ± 9.7 kg/m2; p < 0.0001).
Q7. What was the definition of remission of sleep apnea?
& Remission of sleep apnea was defined as AHI/RDI of less than five off CPAP/BI-PAP on repeat objective testing with polysomnography [14].
Q8. What is the procedure for a stomach anastomosis?
A stapled isoperistaltic sideto-side anastomosis to the anterior wall of the antrum of the stomach is done using a linear cutting stapler, 6 cm proximal to the pylorus.
Q9. What other comorbidities were associated with the SASI bypass?
the SASI bypass was associated with significant improvements in other obesity-associated comorbidities, particularly GERD.
Q10. What was the mean weight of the patients after the SASI bypass?
The mean preoperative weight was 119.3 ± 37.9 (range, 73.6–234) kg and the mean preoperative height was 165.2 ± 8.5 (range, 144–193) cm.A total of 279 patients had T2DM (77.7% were on insulin and 22.3% were on oral antidiabetic medications), 238 had hypertension, 160 had hyperlipidemia, 64 had OSAS, and 76 had gastroesophageal reflux disease (GERD).
Q11. What was the outcome of the pulmonary embolism?
One patient who developed a pulmonary embolism was admitted to the ICU and was treated with intravenous fluids, anticoagulant medications, and thrombolytic therapy.
Q12. What was the %TWL of the patients after the SASI bypass?
Changes in laboratory parameters reflecting the nutritional status at 12 months after SASI bypass included a nonsignificant increase in hemoglobin levels (p = 0.23), a significant decrease in serum iron levels (p = 0.02), a significant decrease in serum albumin levels (p = 0.007), and a significant increase in vitamin D levels (p < 0.0001).
Q13. How many patients showed a complete remission of T2DM?
a total of 277 (99.3%) patients showed either complete remission or partial improvement in their glycemic state after SASI bypass.
Q14. What is the effect of the SASI bypass on the gastrointestinal system?
Regarding the change in nutritional status after SASI bypass, although the reduction in serum albumin levels was significant on the statistical level, it may not be clinically significant since serum albumin levels were within the normal laboratory range indicating that none of the patients developed protein malabsorption after the SASI bypass.
Q15. What was the %TWL of patients who developed complete remission of T2DM?
Patients who developed complete remission of T2DM showed a significant decrease in fasting blood glucose (228.4 ± 103.4 to 100.4 ± 16.1 mg/dl, p < 0.0001) and a significant decrease in HbA1c (8.1 ± 3.6 to 5.3 ± 2.6; p < 0.0001).
Q16. What is the effect of the SASI bypass on GERD?
The increased intra-gastric pressure seenwith the sleeve results in a higher incidence of GERD and possible consequences such as Barrett’s esophagus [22].
Q17. How many patients with T2DM showed a significant improvement in their glycemic?
Eighty-six (36.1%) of 238 patients with hypertension, 104 (65%) of 160 patients with hyperlipidemia, 37 (57.8%) of 64 patients with OSAS, and 70 (92.1%) of 76 patients with GERD showed remission after having the SASI bypass.